A tweet by Sen. Bernie Sanders (I-Vt.) sent a pharmaceutical company's stock reeling on Tuesday.
Eli Lilly's stock dropped nearly 2 percentage points after Sanders criticized the rising price of the company's Humalog brand insulin, citing a Washington Post report on soaring costs of the diabetes drug.
“Why has the price of Humalog insulin gone up 700% in 20 years? It's simple. The drug industry's greed,” Sanders tweeted with a picture of a graph from the Post report.
